Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT02912754 Not yet recruiting - Clinical trials for Leukemia, Lymphocytic, Chronic, B-Cell

Ruxolitinib Combined With Ibrutinib in Chronic Lymphocytic Leukemia Patients

Start date: March 2017
Phase: Phase 1/Phase 2
Study type: Interventional

This study involves adding the kinase inhibitor Ruxolitinib to Ibrutinib to treat Chronic Lymphocytic Leukemia (CLL).

NCT ID: NCT02910947 Not yet recruiting - Clinical trials for Pain Relief to the Patient Following Abdominal Surgeries

Comparative Evaluation of Quadratus Lumborum and Transverses Abdominis Plane Block for Postoperative Pain Relief in Lower Abdominal Surgeries

Start date: October 2016
Phase: Phase 4
Study type: Interventional

Two ultrasound guided techniques to give postoperative pain relief to the patients following abdominal surgeries would be compared using scoring systems for pain relief and scientific methods. while one technique is routinely used, other i.e quadratus lumborum has been recently described and relies on posterior deposition of the drug. Both the techniques are safe and ultrasound imaging is to be used for guidance.

NCT ID: NCT02909413 Not yet recruiting - Clinical trials for Postoperative Cognitive Dysfunction

Comparison of Desflurane With Sevoflurane for School-age Children in Postoperative Cognitive Function

Start date: October 2016
Phase: N/A
Study type: Interventional

This study compares desflurane with sevoflurane for school-age children in postoperative cognitive function.

NCT ID: NCT02908568 Not yet recruiting - Clinical trials for Temporomandibular Joint Disorders

Stimulation of the Proprioceptive Trigeminocardiac Reflex

PTCRSTIM
Start date: September 2016
Phase: Phase 2/Phase 3
Study type: Interventional

Study over muscular stretching to reduce pain the oral cavity.

NCT ID: NCT02906527 Not yet recruiting - Clinical trials for Non Valvular Atrial Fibrillation (nv AF)

Benefit/Risk in Real Life of New Oral Anticoagulants and Vitamin K Antagonists in Patients Aged 75 Years and Over Suffering From Non Valvular Atrial Fibrillation (nv AF)

Presage-Aco
Start date: October 2016
Phase: N/A
Study type: Observational

"The aim of the study is to compare, in real life, the risk benefit (including both major bleeding and thrombotic events (TE) and death from any cause) associated with direct oral anticoagulants (DOAC) and with anti vitamin K (VKA) in older adults (≥ 75 years) suffering from nvAF. The study will be conducted in the French Health insurance database (SNIIRAM). Data of octo+ patients newly treated with an oral anticoagulant (VKA or DOAC) for non valvular atrial fibrillation (nv AF) will be collected from the first exposure of the patient to the drug of interest during the inclusion period to the end of the follow-up period (at least one year of follow-up for each patient)."

NCT ID: NCT02906449 Not yet recruiting - Clinical trials for Brain Concussion, Post-Concussion Syndrome

Investigating the Physiological, Cognitive, and Psychological Effects of a Cognitive-Based Intervention

IPCPE-Mind
Start date: October 2016
Phase: N/A
Study type: Interventional

The primary purpose of this study is to investigate the effectiveness of a brief mindfulness-based intervention for targeting chronic physiological underarousal and post-concussive symptoms following a mild head injury (MHI), as self-reported by undergraduate university students. For the purposes of this study, MHI is defined (and identified) through our demographic questionnaire as a traumatic-based injury to the head - "Have you ever hit your head with a force sufficient to alter your state of consciousness" (consistent with the Kay et al., 1993 criteria/definition; American Congress of Rehabilitation Medicine - ACRM). The investigators exclude congenital or genetic injuries.

NCT ID: NCT02906163 Not yet recruiting - Clinical trials for EGFR Mutation Positive Non Small Cell Lung Cancer

First Line Bio-immunotherapy With Thymosin Alpha 1 in Patients With Sensitizing EGFR Mutation Positive Non Small Cell Lung Cancer Who Are Taking Standard of Care Therapy

Start date: October 2016
Phase: Phase 1/Phase 2
Study type: Interventional

Phase I: evaluate the safety and tolerability two different dosing regimens of Thymosin alpha 1 in patients with advanced EGFR mutation positive NSCLC on Standard of Care (SoC) therapy. Phase II: evaluate the efficacy in terms of PFS of Thymosin alpha 1 in patients with advanced EGFR mutant NSCLC taking SoC as compared to SoC alone.

NCT ID: NCT02905760 Not yet recruiting - Clinical trials for Acute Myocardial Infarction With Right Ventricular Extension

Efficacy of Furosemide Versus Vascular Filling in Patients With Acute Myocardial Infarction

FAMIE
Start date: December 2016
Phase: Phase 3
Study type: Interventional

Right ventricular necrosis increases patient in hospital mortality and can be observed in 20-50% of patients admitted for during acute myocardial infarction. Current guidelines recommend managing cardiogenic shock related to right ventricular necrosis by optimizing RV load using fluid expansion and if insufficient adding inotropic support. However, several experimental studies reported a potential deleterious effect of right ventricular dilation related to fluid expansion because right and left ventricular interaction decreases stroke volume and cardiac output. Consistently with these finding, a study on a small patient sample conducted at Henri Mondor Hospital demonstrates the safety and efficiency of furosemide in patients with right ventricular necrosis. The present study is a phase 3, interventional, prospective, randomized, multicenter, double-blind analysis by intention to treat. The main objective is to demonstrate improved hemodynamic parameters in the short term in patients admitted for acute myocardial infarction with extension RV treated with furosemide. The primary endpoint is compare the change in cardiac output in patients admitted and treated by either fluid expansion or furosemide. The study population will consist in 88 patients and the duration of subjects' participation will be one month.

NCT ID: NCT02903277 Not yet recruiting - Clinical trials for Leukemia, Myelogenous, Chronic, BCR-ABL Positive

National Observatory of Chronic Myeloid Leukemia Adolescent and Young Adults Treated With Tyrosine Kinase Inhibitors in First Intent

Start date: November 2016
Phase: N/A
Study type: Observational

The median age of onset of chronic myeloid leukemia (CML) in chronic phase PC is about 60 years. However CML affects all age groups including 18-25 year olds, called adult-young adolescents (AJA). In France, there is no record of CML and especially not for this particular population, only a European Register of CML in children up to 18 years has been set up under the coordination of Professor "Frederic Millot", pediatrics, CHU Poitiers. Malignancies diagnosed in this population usually have characteristics, evolution, therapeutic strategies with tyrosine kinase inhibitors (TKIs) are a real therapeutic revolution with an overall survival very significantly augmented but at present only a minority of patients may one day consider a final judgment of treatment. AJA are the most exposed patients to the complications, the socio-economic repercussions, professional and personal of a very long-term treatment. But there is little data in the literature concerning this population. Two studies show that diagnosis of CML presents with poor prognostic factors (high skoal), the observed responses are poorer compared to older patients but it is accompanied difference in survival in all cases with a decline of about 70 mois. However, these studies have focused solely on the patients included in the study receiving optimized treatment is not the standard treatment at the time. It is clearly demonstrated that the inclusion in a study brings a benefit to the patient. However, the majority of AJA are not included in a study. The investigators therefore want to describe the AYA population of CML in France and compare the evolution of patients included or not in a protocol. The investigators also want to investigate specific issues of the age of these patients as the reproductive desire. Indeed, while it does not seem to be any risk of teratogenicity for men treated with ITK, this risk is clearly established for women and requires specific supported. Another important point is that of the quality of life. The state of physical and mental health and his feelings, physical activity and its limitations and well-being was assessed by the SF-3612 questionnaire. The results of this analysis were compared with those already obtained for the general population (not representative of Italian adults with cancer sample) and adjusted for sex, age, geographic region, marital status and education level . There seems to be young people and women who express a feeling more pejorative. This does not only covers the frequency of side effects but also on physical activity and well-being. the affected population will be noted that that is particularly involved in the social, professional and in the development of his personal life. The impact of treatment on quality of life must be considered under penalty of seeing the difficulties of compliance. But several studies have demonstrated the negative impact of poor adherence in response to treatments .

NCT ID: NCT02897089 Not yet recruiting - Clinical trials for Dental Caries on Pit and Fissure Surface

Effectiveness of Fissure Sealants Bonded With Different Universal Adhesives

Start date: March 31, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate and compare the clinical retention of a resin-based fissure sealant placed with prior application of etch-and-rinse and self-etch modes of universal adhesives.